NCT01344356 · OUTCOME

Complication Rate

Stereotactic Body Radiotherapy for Head and Neck Tumors · Source last updated 2020-04-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: 5 years

What was measured

Number of participants with any adverse event

Analysis population: 9 patients did not have local control rate data reported. 3 patients were enrolled but never treated. 6 patients were lost to follow up.

Groups in this outcome

Benign Tumors

Benign head and neck tumors will be treated with Stereotactic body radiotherapy stereotactic body radiotherapy: 14-16 Gray / 1 fraction OR 18-21 Gray / 3 fractions (6-7 Gray per fraction)OR 25-45 Gray / 5 fractions (5-9 Gray per fraction)

Unrescectable Malignant Tumors

Malignant Head and Neck Tumors will be treated with Stereotactic body radiotherapy. Stereotactic body radiotherapy: 8-12 Gray / 1 fraction OR 12-18 Gray / 3 fractions (4-6 Gray per fraction) OR 35-45 Gray / 5 fractions (7-9 Gray per fraction)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Benign Tumors	1
Unrescectable Malignant Tumors	9

Reported measurements

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Benign Tumors	1	Not reported	Not reported	Not reported	Not reported
Unrescectable Malignant Tumors	4	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

categories
measurements
group Id
OG000
value
1
group Id
OG001
value
4

denoms

counts
group Id
OG000
value
1
group Id
OG001
value
9
units
Participants

description

Number of participants with any adverse event

groups

description
Benign head and neck tumors will be treated with Stereotactic body radiotherapy stereotactic body radiotherapy: 14-16 Gray / 1 fraction OR 18-21 Gray / 3 fractions (6-7 Gray per fraction)OR 25-45 Gray / 5 fractions (5-9 Gray per fraction)
id
OG000
title
Benign Tumors
description
Malignant Head and Neck Tumors will be treated with Stereotactic body radiotherapy. Stereotactic body radiotherapy: 8-12 Gray / 1 fraction OR 12-18 Gray / 3 fractions (4-6 Gray per fraction) OR 35-45 Gray / 5 fractions (7-9 Gray per fraction)
id
OG001
title
Unrescectable Malignant Tumors

param Type

COUNT_OF_PARTICIPANTS

population Description

9 patients did not have local control rate data reported. 3 patients were enrolled but never treated. 6 patients were lost to follow up.

reporting Status

POSTED

time Frame

5 years

title

Complication Rate

type

PRIMARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice